SCHEMBL3161995

SCHEMBL3161995

Cc1c(Nc2ccc(S(C)(=O)=O)cc2F)ncnc1SC1CCN(OC(=O)OC(C)C)CC1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 19/20 0.59
CYP2C9 P11712 2/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388718 0.89 GPR119 (0.74) GPR119CYP2C9CYP3A4
SCHEMBL3174766 0.85 GPR119 (0.80) GPR119CYP2C9
SCHEMBL3167007 0.81 GPR119 (0.61) GPR119CYP2C9
SCHEMBL3249631 0.79 GPR119 (0.66) GPR119CYP2C9
SCHEMBL3170972 0.78 GPR119 (0.65) GPR119CYP2C9
SCHEMBL3161229 0.78 GPR119 (0.64) GPR119CYP2C9
SCHEMBL4719718 0.77 GPR119 (0.79) GPR119CYP2C9
SCHEMBL3164582 0.77 GPR119 (0.63) GPR119CYP2C9
SCHEMBL4723067 0.77 GPR119 (0.58) GPR119CYP2C9CYP3A4
SCHEMBL3246590 0.76 GPR119 (0.56) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644357-B9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2010-03-24 EP claimed
EP-1644357-B1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2007-12-12 EP claimed